Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TK-112690 with Methotrexate for Mucositis in SCCHN
NCT04046250Phase 2Completed
- Sponsor
- Tosk, Inc.
- Start
- May 2019
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TK-112690 in mucositis, sponsored by Tosk, Inc.. Started May 2019; status: completed.
02
Drugs
TK-112690
03
Conditions
mucositis
Beyond the preview
Go deeper on NCT04046250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04046250.